LSE:VEC (Vectura Group)

About vec

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Vectura Group (LSE: VEC)
Latest News

Investing Articles

Could these 2 pharma growth stocks help you retire early?

Harvey Jones sees plenty to like in these two pharmaceutical stocks, but plenty of uncertainties too.

Read more »

Active senior woman with dog on a walk in a beautiful autumn nature.
Investing Articles

One FTSE 100 income champion and one growth star that could help you retire early

The combination of income and growth from this FTSE 100 (INDEXFTSE: UKX) market leader and its peer could help you…

Read more »

Investing Articles

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright.

Read more »

Investing Articles

Should I swap GlaxoSmithKline plc for this turnaround stock?

Could this company offer higher returns than GlaxoSmithKline plc (LON:GSK)?

Read more »

Investing Articles

Top stocks for December

We asked our analysts to share their top stock picks for the month.

Read more »

Investing Articles

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX).

Read more »

Investing Articles

These growth stocks are trading at major discounts

Are these two companies cheap enough to merit purchase right now?

Read more »

Investing Articles

Top stocks for June

We asked our analysts to share their top stock picks for the coming month.

Read more »